Related references
Note: Only part of the references are listed.Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus
Jiaqi Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease
Hasina Akhter et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Synaptic Alterations in Mouse Models for Alzheimer Disease-A Special Focus on N-Truncated Abeta 4-42
Katharina Dietrich et al.
MOLECULES (2018)
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate
Ting Yang et al.
JOURNAL OF NEUROSCIENCE (2017)
Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity
Levi M. Smith et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
proBDNF Accelerates Brain Amyloid-β Deposition and Learning and Memory Impairment in APPswePS1dE9 Transgenic Mice
Jia Chen et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Morphine Withdrawal Increases Brain-Derived Neurotrophic Factor Precursor
Alessia Bachis et al.
NEUROTOXICITY RESEARCH (2017)
Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression
Shih-Jen Tsai
ONCOTARGET (2017)
Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease
David L. Brody et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment
H. Jiang et al.
TRANSLATIONAL PSYCHIATRY (2017)
Combined serum levels of multiple proteins in tPA-BDNF pathway may aid the diagnosis of five mental disorders
Suzhen Chen et al.
SCIENTIFIC REPORTS (2017)
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits
Gorka Gerenu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Novel Plasminogen Activator Inhibitor-1 Inhibitors Prevent Diabetic Kidney Injury in a Mouse Model
Bo Yeong Jeong et al.
PLOS ONE (2016)
Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease
Ericksen Mielle Borba et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2016)
Rapid Increases in proBDNF after Pilocarpine-Induced Status Epilepticus in Mice Are Associated with Reduced proBDNF Cleavage Machinery
Ajay X. Thomas et al.
ENEURO (2016)
Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease
Shin Bi Oh et al.
BRAIN RESEARCH (2015)
Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease
Orestes Vicente Forlenza et al.
NEUROMOLECULAR MEDICINE (2015)
Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis
Nicolas Pelisch et al.
PLOS ONE (2015)
Extracellular proteolysis in structural and functional plasticity of mossy fiber synapses in hippocampus
Grzegorz Wiera et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2015)
Impact of an additional chronic BDNF reduction on learning performance in an Alzheimer mouse model
Laura Psotta et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Brain-Derived Neurotrophic Factor Plasma Levels: Relationship With Dementia and Diabetes in the Elderly Population
Angela Passaro et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2015)
Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects
Orestes Vicente Forlenza et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease
Jaeho Oh et al.
EXPERIMENTAL GERONTOLOGY (2014)
Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease
Shichun Tu et al.
MOLECULAR NEURODEGENERATION (2014)
Tissue plasminogen activator arrests Alzheimer's disease pathogenesis
Shin Bi Oh et al.
NEUROBIOLOGY OF AGING (2014)
Exogenous t-PA Administration Increases Hippocampal! Mature BDNF Levels. Plasmin- or NMDA-Dependent: Mechanism?
Marion Rodier et al.
PLOS ONE (2014)
proBDNF Negatively Regulates Neuronal Remodeling, Synaptic Transmission, and Synaptic Plasticity in Hippocampus
Jianmin Yang et al.
CELL REPORTS (2014)
A large, cross-sectional observational study of serum BDNF, cognitive function, and mild cognitive function, and mild congnitive impairment in the elderly
Hiroyuki Shimada et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients
Antonio Ciaramella et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
BDNF, TNF alpha, HSP90, CFH, and IL-10 Serum Levels in Patients with Early or Late Onset Alzheimer's Disease or Mild Cognitive Impairment
Duygu Gezen-Ak et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Review: Systemic inflammation and Alzheimer's disease
C. Holmes
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Quercetin protects against the Aβ25-35-induced amnesic injury: Involvement of inactivation of RAGE-mediated pathway and conservation of the NVU
Rui Liu et al.
NEUROPHARMACOLOGY (2013)
Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
Charleine Zussy et al.
PLOS ONE (2013)
Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice
William C. Wetsel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction
Agustin Anastasia et al.
NATURE COMMUNICATIONS (2013)
Involvement of TrkB- and p75NTR-signaling pathways in two contrasting forms of long-lasting synaptic plasticity
Shigeo Sakuragi et al.
SCIENTIFIC REPORTS (2013)
Therapeutic Value of Small Molecule Inhibitor to Plasminogen Activator Inhibitor-1 for Lung Fibrosis
Wen-Tan Huang et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Activators and inhibitors of the plasminogen system in Alzheimer's disease
Rachel Barker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
Aβ Toxicity in Alzheimer's Disease
Virve Cavallucci et al.
MOLECULAR NEUROBIOLOGY (2012)
ProBDNF Collapses Neurite Outgrowth of Primary Neurons by Activating RhoA
Ying Sun et al.
PLOS ONE (2012)
Role of pro-brain-derived neurotrophic factor (proBDNF) to mature BDNF conversion in activity-dependent competition at developing neuromuscular synapses
H. Shawn Je et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Soluble Aβ Oligomers Inhibit Long-Term Potentiation through a Mechanism Involving Excessive Activation of Extrasynaptic NR2B-Containing NMDA Receptors
Shaomin Li et al.
JOURNAL OF NEUROSCIENCE (2011)
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Alan H. Nagahara et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
β-Amyloid impairs axonal BDNF retrograde trafficking
Wayne W. Poon et al.
NEUROBIOLOGY OF AGING (2011)
Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease
R-M Liu et al.
NEUROBIOLOGY OF AGING (2011)
Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration
Ming Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Plasminogen and plasmin in Alzheimer's disease
Rachel Barker et al.
BRAIN RESEARCH (2010)
THE TISSUE PLASMINOGEN ACTIVATOR/PLASMIN SYSTEM MAY ACT THROUGH CLEAVAGE OF PRO-BDNF TO INCREASE RISK OF SUBSTANCE ABUSE
Cheng-Dien Hsu et al.
CNS SPECTRUMS (2010)
Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
F. Angelucci et al.
CURRENT ALZHEIMER RESEARCH (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment
Orestes Vicente Forlenza et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2010)
Tissue-type plasminogen activator-plasmin-BDNF modulate glutamate-induced phase-shifts of the mouse suprachiasmatic circadian clock in vitro
Xiang Mou et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease
Sid E. O'Bryant et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain
Shay Fabbro et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Brain-Derived Neurotrophic Factor Reduces Amyloidogenic Processing through Control of SORLA Gene Expression
Michael Rohe et al.
JOURNAL OF NEUROSCIENCE (2009)
Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease
Alan H. Nagahara et al.
NATURE MEDICINE (2009)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor and Cognitive Function in Non-Demented Subjects
Ge Li et al.
PLOS ONE (2009)
Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
Robert M. Koffie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic
Manuel Yepes et al.
TRENDS IN NEUROSCIENCES (2009)
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Howard Jay Aizenstein et al.
ARCHIVES OF NEUROLOGY (2008)
Transduced PTD-BDNF fusion protein protects against beta amyloid peptide-induced learning and memory deficits in mice
Jian Ping Zhou et al.
BRAIN RESEARCH (2008)
Activation of pro-BDNF by the pericellular serine protease plasmin
Kelly Gray et al.
FEBS LETTERS (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
BDNF: A key regulator for protein synthesis-dependent LTP and long-term memory?
Yuan Lu et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
A Biological Function for the Neuronal Activity-Dependent Component of Bdnf Transcription in the Development of Cortical Inhibition
Elizabeth J. Hong et al.
NEURON (2008)
Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascade
J. Steven Jacobsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls
Christoph Laske et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms
Mathias Cacquevel et al.
NEUROBIOLOGY OF DISEASE (2007)
Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells
Diego J. Garzon et al.
JOURNAL OF NEUROSCIENCE (2007)
Stage-dependent BDNF serum concentrations in Alzheimer's disease
C. Laske et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Clinical relevance of the neurotrophins and their receptors
SJ Allen et al.
CLINICAL SCIENCE (2006)
Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity
Andre L. Samson et al.
NEURON (2006)
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
I Blasko et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
NH Woo et al.
NATURE NEUROSCIENCE (2005)
The yin and yang of neurotrophin action
B Lu et al.
NATURE REVIEWS NEUROSCIENCE (2005)
ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin
HK Teng et al.
JOURNAL OF NEUROSCIENCE (2005)
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease
SY Peng et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation
MG Medina et al.
EMBO JOURNAL (2005)
Tissue plasminogen activator in central nervous system physiology and pathology
JP Melchor et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Structure and function of the plasminogen/plasmin system
FJ Castellino et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Regulation of late-phase UP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF
PT Pang et al.
AGEING RESEARCH REVIEWS (2004)
Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity
PT Pang et al.
SCIENCE (2004)
Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease
B Michalski et al.
MOLECULAR BRAIN RESEARCH (2003)
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains
MD Ledesma et al.
EMBO REPORTS (2003)
Tissue plasminogen activator is required for corticostriatal long-term potentiation
D Centonze et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Regulation of cell survival by secreted proneurotrophins
R Lee et al.
SCIENCE (2001)
β-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand
Y Morishima et al.
JOURNAL OF NEUROSCIENCE (2001)
Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues
H Hino et al.
NEUROSCIENCE LETTERS (2001)
The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
O Nicole et al.
NATURE MEDICINE (2001)
Neurotrophins: Roles in neuronal development and function
EJ Huang et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Tissue plasminogen activator requires plasminogen to modulate amyloid-β neurotoxicity and deposition
HM Tucker et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Region-specific neurotrophin imbalances in Alzheimer disease Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas
C Hock et al.
ARCHIVES OF NEUROLOGY (2000)
Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory
P Calabresi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation
M Zhuo et al.
JOURNAL OF NEUROSCIENCE (2000)
Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease
E Savaskan et al.
EUROPEAN NEUROLOGY (2000)
Share Paper
